NDC 70121-1463 – Fulvestrant

Fulvestrant 250 mg/5mL · Injection, Solution · Intramuscular

Human Prescription Drug

Product NDC70121-1463

Product details

Brand name
Fulvestrant
Generic name
Fulvestrant
Labeler
Amneal Pharmaceuticals LLC
Dosage form
Injection, Solution
Route
Intramuscular
Marketing category
ANDA · ANDA210044
Marketed since
June 3, 2025
Listing expires
December 31, 2026
Pharmacologic class
Estrogen Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Fulvestrant →

Package NDC codes (2)

Package NDCDescriptionSince
70121-1463-22 SYRINGE, GLASS in 1 CARTON (70121-1463-2) / 5 mL in 1 SYRINGE, GLASS (70121-1463-3)Mar 4, 2019
70121-1463-92 SYRINGE, GLASS in 1 CARTON (70121-1463-9) / 5 mL in 1 SYRINGE, GLASS (70121-1463-1)Jun 3, 2025

Other Fulvestrant products